Status:
COMPLETED
Effects of Probiotics on Metabolic Syndrome ,Intestinal Microflora and SCFA.
Lead Sponsor:
Glac Biotech Co., Ltd
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
Phase:
NA
Brief Summary
The improvement effects of GLAC biotech probiotics contains 5 specialized strains on the biochemical analysis and gut microbiota will be verified in the clinical trial through cooperation with the ADP...
Detailed Description
In recent years, the issue of gut microbiota and probiotics has been becoming very popular, and more and more gastrointestinal health foods have been developed and commercialized. The impact of gut mi...
Eligibility Criteria
Inclusion
- The subject are willing to provide physical examination reports within the past 1 year.
- The subject are willing to sign informed consent form.
Exclusion
- Pregnant women or preparing for pregnancy.
- The subject were taking antibiotics.
- One of parents are not Han Chinese or aboriginal.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT06183801
Start Date
August 1 2021
End Date
March 31 2023
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glac Biotech Co., Ltd.
Tainan, Taiwan, 74442